Atrys Health, S.A. (BME:ATRY)
Spain · Delayed Price · Currency is EUR 2.870
-0.055 (-1.88%)
Apr 28, 2026, 2:50 PM CET
Atrys Health Earnings Call Transcripts
Fiscal Year 2024
-
Revenue grew 5% to €107.4M and adjusted EBITDA rose 24.6% to €25.2M, driven by operational efficiencies and strong growth in oncology and prevention. Guidance for 2024 is reaffirmed, with net profit expected to break even in 2025.